Reaction

Varices Oesophageal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,979 reports · 85 co-occurring drugs

As of the last recalculation, Varices Oesophageal appears in 2,979 FAERS reports alongside 85 co-occurring drug terms. The strongest observed disproportionality signal is RIFAXIMIN (PRR 36.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rifaximin	105	36.3	36.4
Nevirapine	37	29.0	29.1
Atezolizumab	149	28.2	28.3
Lactulose	138	26.3	26.4
Tenofovir Disoproxil Fumarate Tablets	32	26.2	26.3
Lamivudine	106	24.8	24.9
Ursosiol	66	24.2	24.3
Ursodiol	71	23.3	23.4
Lamivudine Oral	73	20.6	20.7
Abacavir Sulfate	28	20.3	20.3
Sofosbuvir	55	19.8	19.9
Zidovudine	35	18.5	18.5
Ribavirin	159	18.2	18.2
Bevacizumab	282	17.5	17.5
Efavirenz	26	16.4	16.5
Sorafenib	47	16.0	16.1
Lopinavir And Ritonavir	29	15.1	15.1
Ado-Trastuzumab Emtansine	18	15.0	15.0
Oxaliplatin	149	14.7	14.7
Thiamine Hydrochloride	26	14.7	14.7
Spironolactone	251	13.5	13.6
Tenofovir Disoproxil Fumarate	62	13.4	13.4
Propranolol Hydrochloride	132	13.3	13.4
Entecavir	22	13.3	13.3
Velpatasvir And Sofosbuvir	24	13.2	13.2
Ritonavir	48	11.6	11.7
Atazanavir	22	10.8	10.8
Raltegravir	25	10.7	10.7
Ledipasvir And Sofosbuvir	28	10.3	10.3
Peginterferon Alfa-2A	75	9.9	9.9
Ritonavir 100 Mg	20	9.4	9.4
Cholestyramine	15	8.7	8.7
Dalteparin Sodium	13	8.6	8.6
Fluorouracil Cream, 0.5%	88	8.3	8.3
Fluorouracil	88	8.2	8.2
Irinotecan Hydrochloride	14	7.6	7.6
Panitumumab	17	7.6	7.6
Capecitabine	94	7.4	7.4
Octreotide Acetate	30	6.9	6.9
Hydroxyurea	20	6.6	6.7
Leucovorin Calcium	18	6.6	6.6
Magnesium Sulfate In Water For	12	6.6	6.6
Erlotinib	9	6.5	6.5
Magnesium Sulfate Heptahydrate	12	6.5	6.5
Magnesium Sulfate	12	6.4	6.5
Erlotinib Hydrochloride	11	6.2	6.2
Torsemide	28	6.0	6.0
Glecaprevir And Pibrentasvir	9	5.7	5.7
Ferrous Sulfate	40	5.6	5.6
Lenvatinib	26	5.6	5.6
Crizotinib	10	5.5	5.5
Dextrose	10	5.3	5.3
Dextrose Monohydrate	10	5.2	5.2
Teduglutide	10	5.2	5.2
Insulin	41	5.2	5.2
Carvedilol	85	4.5	4.5
Macitentan	42	4.3	4.3
Mesna Injection	5	4.2	4.2
Linagliptin	11	4.2	4.2
Mesna	5	4.2	4.2
Granisetron Hydrochloride	6	4.0	4.0
Dolutegravir Sodium	5	3.9	3.9
Ruxolitinib	39	3.8	3.8
Gemcitabine	21	3.7	3.7
Romiplostim	8	3.7	3.7
Regorafenib	6	3.6	3.6
Cetuximab	16	3.6	3.6
Fosaprepitant Dimeglumine	7	3.6	3.6
Emtricitabine And Tenofovir Disoproxil Fumarate	23	3.5	3.5
Canagliflozin	15	3.5	3.5
Fam-Trastuzumab Deruxtecan-Nxki	5	3.5	3.5
Iohexol	4	3.4	3.4
Tolvaptan	7	3.4	3.4
Trifluridine And Tipiracil	5	3.3	3.3
Bosentan	21	2.9	2.9
Gemcitabine Hydrochloride	22	2.9	2.9
Inclisiran	3	2.6	2.6
Pemetrexed	8	2.6	2.6
Insulin Lispro	49	2.5	2.5
Ustekinumab	34	2.3	2.3
Guselkumab	11	2.2	2.2
Eltrombopag Olamine	7	2.1	2.1
Durvalumab	6	2.1	2.1
Treprostinil	36	2.0	2.0
Apremilast	21	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.